The metabolic hormone adiponectin affects the correlation between nutritional status and pneumococcal vaccine response in vulnerable indigenous children

PLoS One. 2022 Jul 21;17(7):e0270736. doi: 10.1371/journal.pone.0270736. eCollection 2022.

Abstract

Background: Almost 200 million children worldwide are either undernourished or overweight. Only a few studies have addressed the effect of variation in nutritional status on vaccine response. We previously demonstrated an association between stunting and an increased post-vaccination 13-valent pneumococcal conjugate vaccine (PCV13) response. In this prospective study, we assessed to what extent metabolic hormones may be a modifier in the association between nutritional status and PCV13 response.

Methods: Venezuelan children aged 6 weeks to 59 months were vaccinated with a primary series of PCV13. Nutritional status and serum levels of leptin, adiponectin and ghrelin were measured upon vaccination and their combined effect on serum post-vaccination antibody concentrations was assessed by generalized estimating equations multivariable regression analysis.

Results: A total of 210 children were included, of whom 80 were stunted, 81 had a normal weight and 49 were overweight. Overweight children had lower post-vaccination antibody concentrations than normal weight children (regression coefficient -1.15, 95% CI -2.22 --0.072). Additionally, there was a significant adiponectin-nutritional status interaction. In stunted children, higher adiponectin serum concentrations were associated with lower post-PCV13 antibody concentrations (regression coefficient -0.19, 95% CI -0.24 --0.14) while the opposite was seen in overweight children (regression coefficient 0.14, 95% CI 0.049-0.22).

Conclusion: Metabolic hormones, in particular adiponectin, may modify the effect of nutritional status on pneumococcal vaccine response. These findings emphasize the importance of further research to better understand the immunometabolic pathways underlying vaccine response and enable a future of optimal personalized vaccination schedules.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adiponectin
  • Child
  • Humans
  • Infant
  • Nutritional Status
  • Overweight
  • Pneumococcal Infections* / prevention & control
  • Pneumococcal Vaccines
  • Prospective Studies
  • Vaccination
  • Vaccines, Conjugate

Substances

  • Adiponectin
  • Pneumococcal Vaccines
  • Vaccines, Conjugate

Associated data

  • Dryad/10.5061/dryad.0gb5mkm1s

Grants and funding

The original study was supported by Pfizer Venezuela and the Fundacion para la Investigación en Micobacterias, Caracas, Venezuela. None of the authors are affiliated with Pfizer Venezuela. LMV was supported by a Clinical Research Talent fellowship of the UMC Utrecht, The Netherlands. Further, LMV was granted a Pichichero Family Foundation Vaccines for Children Initiative Research Award from the Pediatric Infectious Diseases Society Foundation. The funder did not provide support in the form of salaries for authors and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.